In this regard, even if the expression of TBX3 and SIRT6 is inversely correlated in both basal-like and HER2-positive breast cancer patients, their paired expression levels have opposite predictive meanings in these two cancer subtypes. Here, ERBB2 is linked to breast carcinoma.